The New York Times is releasing a series of data files with cumulative counts of coronavirus cases in the United States, at the state and county level, over time. We are compiling this time series data from state and local governments and health departments in an attempt to provide a complete record of the ongoing outbreak.
Since late January, The Times has tracked cases of coronavirus in real time as they were identified after testing. Because of the widespread shortage of testing, however, the data is necessarily limited in the picture it presents of the outbreak.
We have used this data to power our maps and reporting tracking the outbreak, and it is now being made available to the public in response to requests from researchers, scientists and government officials who would like access to the data to better understand the outbreak.
The data begins with the first reported coronavirus case in Washington State on Jan. 21, 2020. We will publish regular updates to the data in this repository.
As of May 31, some 56 percent of respondents in the United States stated that they will try and avoid sports events once the restrictions due to COVID-19 / coronavirus are lifted.
A recent survey from IPSOS found that nearly two thirds of respondents from Japan and India strongly or somewhat agreed that restrictions on travel and self-isolation would not stop the spread of the coronavirus (COVID-19), compared to only one third of Canadians. This statistic shows the percentage of respondents worldwide who felt that travel restrictions and self-isolation would not stop the spread of COVID-19 as of March 21, 2020, by country.
Note: Reporting of new COVID-19 Case Surveillance data will be discontinued July 1, 2024, to align with the process of removing SARS-CoV-2 infections (COVID-19 cases) from the list of nationally notifiable diseases. Although these data will continue to be publicly available, the dataset will no longer be updated.
Authorizations to collect certain public health data expired at the end of the U.S. public health emergency declaration on May 11, 2023. The following jurisdictions discontinued COVID-19 case notifications to CDC: Iowa (11/8/21), Kansas (5/12/23), Kentucky (1/1/24), Louisiana (10/31/23), New Hampshire (5/23/23), and Oklahoma (5/2/23). Please note that these jurisdictions will not routinely send new case data after the dates indicated. As of 7/13/23, case notifications from Oregon will only include pediatric cases resulting in death.
This case surveillance public use dataset has 19 elements for all COVID-19 cases shared with CDC and includes demographics, geography (county and state of residence), any exposure history, disease severity indicators and outcomes, and presence of any underlying medical conditions and risk behaviors.
Currently, CDC provides the public with three versions of COVID-19 case surveillance line-listed data: this 19 data element dataset with geography, a 12 data element public use dataset, and a 33 data element restricted access dataset.
The following apply to the public use datasets and the restricted access dataset:
Overview
The COVID-19 case surveillance database includes individual-level data reported to U.S. states and autonomous reporting entities, including New York City and the District of Columbia (D.C.), as well as U.S. territories and affiliates. On April 5, 2020, COVID-19 was added to the Nationally Notifiable Condition List and classified as “immediately notifiable, urgent (within 24 hours)” by a Council of State and Territorial Epidemiologists (CSTE) Interim Position Statement (<a href="https://cdn.ymaws.com/www.cste.org/resource/resmgr/ps/positionstatement2020/Interim-20-ID-01_COVID
On March 10, 2023, the Johns Hopkins Coronavirus Resource Center ceased its collecting and reporting of global COVID-19 data. For updated cases, deaths, and vaccine data please visit: World Health Organization (WHO)For more information, visit the Johns Hopkins Coronavirus Resource Center.COVID-19 Trends MethodologyOur goal is to analyze and present daily updates in the form of recent trends within countries, states, or counties during the COVID-19 global pandemic. The data we are analyzing is taken directly from the Johns Hopkins University Coronavirus COVID-19 Global Cases Dashboard, though we expect to be one day behind the dashboard’s live feeds to allow for quality assurance of the data.DOI: https://doi.org/10.6084/m9.figshare.125529863/7/2022 - Adjusted the rate of active cases calculation in the U.S. to reflect the rates of serious and severe cases due nearly completely dominant Omicron variant.6/24/2020 - Expanded Case Rates discussion to include fix on 6/23 for calculating active cases.6/22/2020 - Added Executive Summary and Subsequent Outbreaks sectionsRevisions on 6/10/2020 based on updated CDC reporting. This affects the estimate of active cases by revising the average duration of cases with hospital stays downward from 30 days to 25 days. The result shifted 76 U.S. counties out of Epidemic to Spreading trend and no change for national level trends.Methodology update on 6/2/2020: This sets the length of the tail of new cases to 6 to a maximum of 14 days, rather than 21 days as determined by the last 1/3 of cases. This was done to align trends and criteria for them with U.S. CDC guidance. The impact is areas transition into Controlled trend sooner for not bearing the burden of new case 15-21 days earlier.Correction on 6/1/2020Discussion of our assertion of an abundance of caution in assigning trends in rural counties added 5/7/2020. Revisions added on 4/30/2020 are highlighted.Revisions added on 4/23/2020 are highlighted.Executive SummaryCOVID-19 Trends is a methodology for characterizing the current trend for places during the COVID-19 global pandemic. Each day we assign one of five trends: Emergent, Spreading, Epidemic, Controlled, or End Stage to geographic areas to geographic areas based on the number of new cases, the number of active cases, the total population, and an algorithm (described below) that contextualize the most recent fourteen days with the overall COVID-19 case history. Currently we analyze the countries of the world and the U.S. Counties. The purpose is to give policymakers, citizens, and analysts a fact-based data driven sense for the direction each place is currently going. When a place has the initial cases, they are assigned Emergent, and if that place controls the rate of new cases, they can move directly to Controlled, and even to End Stage in a short time. However, if the reporting or measures to curtail spread are not adequate and significant numbers of new cases continue, they are assigned to Spreading, and in cases where the spread is clearly uncontrolled, Epidemic trend.We analyze the data reported by Johns Hopkins University to produce the trends, and we report the rates of cases, spikes of new cases, the number of days since the last reported case, and number of deaths. We also make adjustments to the assignments based on population so rural areas are not assigned trends based solely on case rates, which can be quite high relative to local populations.Two key factors are not consistently known or available and should be taken into consideration with the assigned trend. First is the amount of resources, e.g., hospital beds, physicians, etc.that are currently available in each area. Second is the number of recoveries, which are often not tested or reported. On the latter, we provide a probable number of active cases based on CDC guidance for the typical duration of mild to severe cases.Reasons for undertaking this work in March of 2020:The popular online maps and dashboards show counts of confirmed cases, deaths, and recoveries by country or administrative sub-region. Comparing the counts of one country to another can only provide a basis for comparison during the initial stages of the outbreak when counts were low and the number of local outbreaks in each country was low. By late March 2020, countries with small populations were being left out of the mainstream news because it was not easy to recognize they had high per capita rates of cases (Switzerland, Luxembourg, Iceland, etc.). Additionally, comparing countries that have had confirmed COVID-19 cases for high numbers of days to countries where the outbreak occurred recently is also a poor basis for comparison.The graphs of confirmed cases and daily increases in cases were fit into a standard size rectangle, though the Y-axis for one country had a maximum value of 50, and for another country 100,000, which potentially misled people interpreting the slope of the curve. Such misleading circumstances affected comparing large population countries to small population counties or countries with low numbers of cases to China which had a large count of cases in the early part of the outbreak. These challenges for interpreting and comparing these graphs represent work each reader must do based on their experience and ability. Thus, we felt it would be a service to attempt to automate the thought process experts would use when visually analyzing these graphs, particularly the most recent tail of the graph, and provide readers with an a resulting synthesis to characterize the state of the pandemic in that country, state, or county.The lack of reliable data for confirmed recoveries and therefore active cases. Merely subtracting deaths from total cases to arrive at this figure progressively loses accuracy after two weeks. The reason is 81% of cases recover after experiencing mild symptoms in 10 to 14 days. Severe cases are 14% and last 15-30 days (based on average days with symptoms of 11 when admitted to hospital plus 12 days median stay, and plus of one week to include a full range of severely affected people who recover). Critical cases are 5% and last 31-56 days. Sources:U.S. CDC. April 3, 2020 Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). Accessed online. Initial older guidance was also obtained online. Additionally, many people who recover may not be tested, and many who are, may not be tracked due to privacy laws. Thus, the formula used to compute an estimate of active cases is: Active Cases = 100% of new cases in past 14 days + 19% from past 15-25 days + 5% from past 26-49 days - total deaths. On 3/17/2022, the U.S. calculation was adjusted to: Active Cases = 100% of new cases in past 14 days + 6% from past 15-25 days + 3% from past 26-49 days - total deaths. Sources: https://www.cdc.gov/mmwr/volumes/71/wr/mm7104e4.htm https://covid.cdc.gov/covid-data-tracker/#variant-proportions If a new variant arrives and appears to cause higher rates of serious cases, we will roll back this adjustment. We’ve never been inside a pandemic with the ability to learn of new cases as they are confirmed anywhere in the world. After reviewing epidemiological and pandemic scientific literature, three needs arose. We need to specify which portions of the pandemic lifecycle this map cover. The World Health Organization (WHO) specifies six phases. The source data for this map begins just after the beginning of Phase 5: human to human spread and encompasses Phase 6: pandemic phase. Phase six is only characterized in terms of pre- and post-peak. However, these two phases are after-the-fact analyses and cannot ascertained during the event. Instead, we describe (below) a series of five trends for Phase 6 of the COVID-19 pandemic.Choosing terms to describe the five trends was informed by the scientific literature, particularly the use of epidemic, which signifies uncontrolled spread. The five trends are: Emergent, Spreading, Epidemic, Controlled, and End Stage. Not every locale will experience all five, but all will experience at least three: emergent, controlled, and end stage.This layer presents the current trends for the COVID-19 pandemic by country (or appropriate level). There are five trends:Emergent: Early stages of outbreak. Spreading: Early stages and depending on an administrative area’s capacity, this may represent a manageable rate of spread. Epidemic: Uncontrolled spread. Controlled: Very low levels of new casesEnd Stage: No New cases These trends can be applied at several levels of administration: Local: Ex., City, District or County – a.k.a. Admin level 2State: Ex., State or Province – a.k.a. Admin level 1National: Country – a.k.a. Admin level 0Recommend that at least 100,000 persons be represented by a unit; granted this may not be possible, and then the case rate per 100,000 will become more important.Key Concepts and Basis for Methodology: 10 Total Cases minimum threshold: Empirically, there must be enough cases to constitute an outbreak. Ideally, this would be 5.0 per 100,000, but not every area has a population of 100,000 or more. Ten, or fewer, cases are also relatively less difficult to track and trace to sources. 21 Days of Cases minimum threshold: Empirically based on COVID-19 and would need to be adjusted for any other event. 21 days is also the minimum threshold for analyzing the “tail” of the new cases curve, providing seven cases as the basis for a likely trend (note that 21 days in the tail is preferred). This is the minimum needed to encompass the onset and duration of a normal case (5-7 days plus 10-14 days). Specifically, a median of 5.1 days incubation time, and 11.2 days for 97.5% of cases to incubate. This is also driven by pressure to understand trends and could easily be adjusted to 28 days. Source
In May 2020, approximately 34 percent of respondents in the United Kingdom and 38 percent of European respondents, planned to book their next vacation abroad during 2021. The majority of respondents for both regions expected to go on international holiday already during 2020, provided that the travel restrictions imposed due to the coronavirus (COVID-19) pandemic are lifted.
https://www.etalab.gouv.fr/licence-ouverte-open-licencehttps://www.etalab.gouv.fr/licence-ouverte-open-licence
Public Health France’s mission is to improve and protect the health of populations. During the health crisis linked to the COVID-19 outbreak, Santé publique France is responsible for monitoring and understanding the dynamics of the epidemic, anticipating the various scenarios and putting in place actions to prevent and limit the transmission of this virus on national territory.
The new screening information system (SI-DEP), which has been in operation since 13 May 2020, is a secure platform where the results of the laboratory tests carried out by all city and hospital laboratories for SARS-COV2 are systematically recorded.
The creation of this information system is authorised for a period of 6 months from the end of the state of health emergency by application of Decree No 2020-551 of 12 May 2020 on the information systems referred to in Article 11 of Law No 2020-546 of 11 May 2020 extending the state of health emergency and supplementing its provisions.
This dataset provides information at the departmental and regional level: — the daily and weekly incidence rate per age group; — the daily and weekly standardised incidence rate; — the sliding standardised incidence rate.
This dataset provides information at the national level: — the daily and weekly incidence rate by age group and sex; — the daily and weekly standardised incidence rate; — the sliding standardised incidence rate.
The incidence rate corresponds to the number of positive tests per 100,000 inhabitants. It shall be calculated as follows: (100000 * number of positive cases)/Population
Accuracy: — From 29/08 onwards, laboratory data indicators (SI-DEP) show rates of incidence, positivity and screening adjusted for screenings conducted at airports upon arrival of international flights. — For more information, see the methodological note available in the resources. Limits: — Only the biological tests of persons for whom the residence department could be located are shown on the maps. Persons whose department could not be traced in the SIDEP data are counted only at the whole French level. As a result, the sum of the tests indicated in the departments or regions is less than the number of tests indicated in France. — The time limit for repeating tests may exceed 9 days in some cases. The indicators are adjusted daily according to the receipt of the results.
Since 8 December, after verifying the quality of the reported data, all results of RT-PCR or Antigenic tests have been included in the production of national and territorial epidemiological indicators (incidence rates, positivity rates and screening rates) relevant to the monitoring of the COVID-19 outbreak. On the other hand, the epidemic is prolonging in time and screening capacities have increased, leading to an increasing frequency of people tested several times. Thus, an adjustment of the methods of splitting for patients benefiting from repeated tests and therefore the definition of the persons tested was necessary. Public Health France, in its patient-centred epidemiological approach, has therefore adapted its methods to ensure that these indicators reflect, in particular, the proportion of infected people among the population tested. These developments have no impact on the trends and interpretation of the dynamics of the epidemic, which remain the same. More precise test data (impact and positivity) are also published by Santé publique France (SI-DEP data).
Beginning March 1, 2022, the "COVID-19 Case Surveillance Public Use Data" will be updated on a monthly basis. This case surveillance public use dataset has 12 elements for all COVID-19 cases shared with CDC and includes demographics, any exposure history, disease severity indicators and outcomes, presence of any underlying medical conditions and risk behaviors, and no geographic data. CDC has three COVID-19 case surveillance datasets: COVID-19 Case Surveillance Public Use Data with Geography: Public use, patient-level dataset with clinical data (including symptoms), demographics, and county and state of residence. (19 data elements) COVID-19 Case Surveillance Public Use Data: Public use, patient-level dataset with clinical and symptom data and demographics, with no geographic data. (12 data elements) COVID-19 Case Surveillance Restricted Access Detailed Data: Restricted access, patient-level dataset with clinical and symptom data, demographics, and state and county of residence. Access requires a registration process and a data use agreement. (32 data elements) The following apply to all three datasets: Data elements can be found on the COVID-19 case report form located at www.cdc.gov/coronavirus/2019-ncov/downloads/pui-form.pdf. Data are considered provisional by CDC and are subject to change until the data are reconciled and verified with the state and territorial data providers. Some data cells are suppressed to protect individual privacy. The datasets will include all cases with the earliest date available in each record (date received by CDC or date related to illness/specimen collection) at least 14 days prior to the creation of the previously updated datasets. This 14-day lag allows case reporting to be stabilized and ensures that time-dependent outcome data are accurately captured. Datasets are updated monthly. Datasets are created using CDC’s operational Policy on Public Health Research and Nonresearch Data Management and Access and include protections designed to protect individual privacy. For more information about data collection and reporting, please see https://wwwn.cdc.gov/nndss/data-collection.html For more information about the COVID-19 case surveillance data, please see https://www.cdc.gov/coronavirus/2019-ncov/covid-data/faq-surveillance.html Overview The COVID-19 case surveillance database includes individual-level data reported to U.S. states and autonomous reporting entities, including New York City and the District of Columbia (D.C.), as well as U.S. territories and affiliates. On April 5, 2020, COVID-19 was added to the Nationally Notifiable Condition List and classified as “immediately notifiable, urgent (within 24 hours)” by a Council of State and Territorial Epidemiologists (CSTE) Interim Position Statement (Interim-20-ID-01). CSTE updated the position statement on August 5, 2020 to clarify the interpretation of antigen detection tests and serologic test results within the case classification. The statement also recommended that all states and territories enact laws to make COVID-19 reportable in their jurisdiction, and that jurisdictions conducting surveillance should submit case notifications to CDC. COVID-19 case surveillance data are collected by jurisdictions and reported volun
In May 2020, over one half of respondents in both the United Kingdom (UK) and Europe, planned to book a domestic holiday in summer 2020, provided that the travel restrictions imposed due to the coronavirus (COVID-19) pandemic were lifted. Very few respondents in both regions said they would not travel domestically until a vaccine was found and/or the economic situation had stabilized.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
This dataset contains numbers of COVID-19 outbreaks and associated cases, categorized by setting, reported to CDPH since January 1, 2021.
AB 685 (Chapter 84, Statutes of 2020) and the Cal/OSHA COVID-19 Emergency Temporary Standards (Title 8, Subchapter 7, Sections 3205-3205.4) required non-healthcare employers in California to report workplace COVID-19 outbreaks to their local health department (LHD) between January 1, 2021 – December 31, 2022. Beginning January 1, 2023, non-healthcare employer reporting of COVID-19 outbreaks to local health departments is voluntary, unless a local order is in place. More recent data collected without mandated reporting may therefore be less representative of all outbreaks that have occurred, compared to earlier data collected during mandated reporting. Licensed health facilities continue to be mandated to report outbreaks to LHDs.
LHDs report confirmed outbreaks to the California Department of Public Health (CDPH) via the California Reportable Disease Information Exchange (CalREDIE), the California Connected (CalCONNECT) system, or other established processes. Data are compiled and categorized by setting by CDPH. Settings are categorized by U.S. Census industry codes. Total outbreaks and cases are included for individual industries as well as for broader industrial sectors.
The first dataset includes numbers of outbreaks in each setting by month of onset, for outbreaks reported to CDPH since January 1, 2021. This dataset includes some outbreaks with onset prior to January 1 that were reported to CDPH after January 1; these outbreaks are denoted with month of onset “Before Jan 2021.” The second dataset includes cumulative numbers of COVID-19 outbreaks with onset after January 1, 2021, categorized by setting. Due to reporting delays, the reported numbers may not reflect all outbreaks that have occurred as of the reporting date; additional outbreaks may have occurred that have not yet been reported to CDPH.
While many of these settings are workplaces, cases may have occurred among workers, other community members who visited the setting, or both. Accordingly, these data do not distinguish between outbreaks involving only workers, outbreaks involving only residents or patrons, or outbreaks involving both.
Several additional data limitations should be kept in mind:
Outbreaks are classified as “Insufficient information” for outbreaks where not enough information was available for CDPH to assign an industry code.
Some sectors, particularly congregate residential settings, may have increased testing and therefore increased likelihood of outbreak recognition and reporting. As a result, in congregate residential settings, the number of outbreak-associated cases may be more accurate.
However, in most settings, outbreak and case counts are likely underestimates. For most cases, it is not possible to identify the source of exposure, as many cases have multiple possible exposures.
Because some settings have been at times been closed or open with capacity restrictions, numbers of outbreak reports in those settings do not reflect COVID-19 transmission risk.
The number of outbreaks in different settings will depend on the number of different workplaces in each setting. More outbreaks would be expected in settings with many workplaces compared to settings with few workplaces.
Notice of data discontinuation: Since the start of the pandemic, AP has reported case and death counts from data provided by Johns Hopkins University. Johns Hopkins University has announced that they will stop their daily data collection efforts after March 10. As Johns Hopkins stops providing data, the AP will also stop collecting daily numbers for COVID cases and deaths. The HHS and CDC now collect and visualize key metrics for the pandemic. AP advises using those resources when reporting on the pandemic going forward.
April 9, 2020
April 20, 2020
April 29, 2020
September 1st, 2020
February 12, 2021
new_deaths
column.February 16, 2021
The AP is using data collected by the Johns Hopkins University Center for Systems Science and Engineering as our source for outbreak caseloads and death counts for the United States and globally.
The Hopkins data is available at the county level in the United States. The AP has paired this data with population figures and county rural/urban designations, and has calculated caseload and death rates per 100,000 people. Be aware that caseloads may reflect the availability of tests -- and the ability to turn around test results quickly -- rather than actual disease spread or true infection rates.
This data is from the Hopkins dashboard that is updated regularly throughout the day. Like all organizations dealing with data, Hopkins is constantly refining and cleaning up their feed, so there may be brief moments where data does not appear correctly. At this link, you’ll find the Hopkins daily data reports, and a clean version of their feed.
The AP is updating this dataset hourly at 45 minutes past the hour.
To learn more about AP's data journalism capabilities for publishers, corporations and financial institutions, go here or email kromano@ap.org.
Use AP's queries to filter the data or to join to other datasets we've made available to help cover the coronavirus pandemic
Filter cases by state here
Rank states by their status as current hotspots. Calculates the 7-day rolling average of new cases per capita in each state: https://data.world/associatedpress/johns-hopkins-coronavirus-case-tracker/workspace/query?queryid=481e82a4-1b2f-41c2-9ea1-d91aa4b3b1ac
Find recent hotspots within your state by running a query to calculate the 7-day rolling average of new cases by capita in each county: https://data.world/associatedpress/johns-hopkins-coronavirus-case-tracker/workspace/query?queryid=b566f1db-3231-40fe-8099-311909b7b687&showTemplatePreview=true
Join county-level case data to an earlier dataset released by AP on local hospital capacity here. To find out more about the hospital capacity dataset, see the full details.
Pull the 100 counties with the highest per-capita confirmed cases here
Rank all the counties by the highest per-capita rate of new cases in the past 7 days here. Be aware that because this ranks per-capita caseloads, very small counties may rise to the very top, so take into account raw caseload figures as well.
The AP has designed an interactive map to track COVID-19 cases reported by Johns Hopkins.
@(https://datawrapper.dwcdn.net/nRyaf/15/)
<iframe title="USA counties (2018) choropleth map Mapping COVID-19 cases by county" aria-describedby="" id="datawrapper-chart-nRyaf" src="https://datawrapper.dwcdn.net/nRyaf/10/" scrolling="no" frameborder="0" style="width: 0; min-width: 100% !important;" height="400"></iframe><script type="text/javascript">(function() {'use strict';window.addEventListener('message', function(event) {if (typeof event.data['datawrapper-height'] !== 'undefined') {for (var chartId in event.data['datawrapper-height']) {var iframe = document.getElementById('datawrapper-chart-' + chartId) || document.querySelector("iframe[src*='" + chartId + "']");if (!iframe) {continue;}iframe.style.height = event.data['datawrapper-height'][chartId] + 'px';}}});})();</script>
Johns Hopkins timeseries data - Johns Hopkins pulls data regularly to update their dashboard. Once a day, around 8pm EDT, Johns Hopkins adds the counts for all areas they cover to the timeseries file. These counts are snapshots of the latest cumulative counts provided by the source on that day. This can lead to inconsistencies if a source updates their historical data for accuracy, either increasing or decreasing the latest cumulative count. - Johns Hopkins periodically edits their historical timeseries data for accuracy. They provide a file documenting all errors in their timeseries files that they have identified and fixed here
This data should be credited to Johns Hopkins University COVID-19 tracking project
Abstract: The stay at home restrictions to control the spread of COVID-19 led to unparalleled sudden change in daily life, but it is unclear how they affected urban crime globally. We collected data on daily counts of crime in 26 cities across 22 countries in the Americas, Europe, the Middle East and Asia. We conducted interrupted time series analyses to assess the impact of stay at home restrictions on different types of crime in each city. Our findings show that the stay at home policies were associated with a considerable drop in urban crime, but with substantial variation across cities and types of crime. Meta-regression results showed that more stringent restrictions over movement in public space were predictive of larger declines in crime.
This case surveillance publicly available dataset has 32 elements for all COVID-19 cases shared with CDC and includes demographics, geography (county and state of residence), any exposure history, disease severity indicators and outcomes, and presence of any underlying medical conditions and risk behaviors. This dataset requires a registration process and a data use agreement. CDC has three COVID-19 case surveillance datasets: COVID-19 Case Surveillance Public Use Data with Geography: Public use, patient-level dataset with clinical data (including symptoms), demographics, and county and state of residence. (19 data elements) COVID-19 Case Surveillance Public Use Data: Public use, patient-level dataset with clinical and symptom data and demographics, with no geographic data. (12 data elements) COVID-19 Case Surveillance Restricted Access Data: Restricted access, patient-level dataset with clinical (including symptoms), demographics, and county and state of residence. Access requires a registration process and a data use agreement. (32 data elements) Requesting Access to the COVID-19 Case Surveillance Restricted Access Detailed Data Please review the following documents to determine your interest in accessing the COVID-19 Case Surveillance Restricted Access Detailed Data file: 1) CDC COVID-19 Case Surveillance Restricted Access Detailed Data: Summary, Guidance, Limitations Information, and Restricted Access Data Use Agreement Information 2) Data Dictionary for the COVID-19 Case Surveillance Restricted Access Detailed Data The next step is to complete the Registration Information and Data Use Restrictions Agreement (RIDURA). Once complete, CDC will review your agreement. After access is granted, Ask SRRG (eocevent394@cdc.gov) will email you information about how to access the data through GitHub. If you have questions about obtaining access, email eocevent394@cdc.gov. Overview The COVID-19 case surveillance database includes patient-level data reported by U.S. states and autonomous reporting entities, including New York City, the District of Columbia, as well as U.S. territories and affiliates. On April 5, 2020, COVID-19 was added to the Nationally Notifiable Condition List and classified as “immediately notifiable, urgent (within 24 hours)” by a Council of State and Territorial Epidemiologists (CSTE) Interim Position Statement (Interim-20-ID-01). CSTE updated the position statement on August 5, 2020, to clarify the interpretation of antigen detection tests and serologic test results within the case classification. The statement also recommended that all states and territories enact laws to make COVID-19 reportable in their jurisdiction, and that jurisdictions conducting surveillance should submit case notifications to CDC. COVID-19 case surveillance data are collected by jurisdictions and are shared voluntarily with CDC. For more information, visit: <a href="https://wwwn.cdc.gov/nndss/conditions/coronavirus-disease-2019-c
As of May 2020, approximately 47 percent of Indonesian respondents surveyed stated that they agreed with the government's plan to relax restrictions related to the coronavirus (COVID-19) pandemic. Meanwhile, 1.4 percent of respondents said that they absolutely disagreed with the government's plan to relax such restrictions.
Official statistics are produced impartially and free from political influence.
This is a record of the discussion of SAGE 23 on 7 April 2020.
It should be viewed in context: the paper was the best assessment of the evidence at the time of writing. The picture is developing rapidly and, as new evidence or data emerges, SAGE updates its advice accordingly.
Therefore, some of the information in this paper may have been superseded and the author’s opinion or conclusion may since have developed.
These documents are released as pre-print publications that have provided the government with rapid evidence during an emergency. These documents have not been peer-reviewed and there is no restriction on authors submitting and publishing this evidence in peer-reviewed journals.
Redactions within this document have been made to remove any names of junior officials (not Senior Civil Service) or names of anyone for national security reasons. SAGE 23 includes redactions of 5 junior officials and 1 official for national security reasons.
Abstract copyright UK Data Service and data collection copyright owner.
The UCL COVID-19 Social Study at University College London (UCL) was launched on 21 March 2020. Led by Dr Daisy Fancourt and Professor Andrew Steptoe from the Department of Behavioural Science and Health, the team designed the study to track in real-time the psychological and social impact of the virus across the UK.
The study quickly became the largest in the country, growing to over 70,000 participants and providing rare and privileged insight into the effects of the pandemic on people’s daily lives. Through our participants’ remarkable two-year commitment to the study, 1.2 million surveys were collected over 105 weeks, and over 100 scientific papers and 44 public reports were published.
During COVID-19, population mental health has been affected both by the intensity of the pandemic (cases and death rates), but also by lockdowns and restrictions themselves. Worsening mental health coincided with higher rates of COVID-19, tighter restrictions, and the weeks leading up to lockdowns. Mental health then generally improved during lockdowns and most people were able to adapt and manage their well-being. However, a significant proportion of the population suffered disproportionately to the rest, and stay-at-home orders harmed those who were already financially, socially, or medically vulnerable. Socioeconomic factors, including low SEP, low income, and low educational attainment, continued to be associated with worse experiences of the pandemic. Outcomes for these groups were worse throughout many measures including mental health and wellbeing; financial struggles;self-harm and suicide risk; risk of contracting COVID-19 and developing long Covid; and vaccine resistance and hesitancy. These inequalities existed before the pandemic and were further exacerbated by COVID-19, and such groups remain particularly vulnerable to the future effects of the pandemic and other national crises.
Further information, including reports and publications, can be found on the UCL COVID-19 Social Study website.
The study asked baseline questions on the following:
It also asked repeated questions at every wave on the following:
Certain waves of the study also included one-off modules on topics including volunteering behaviours, locus of control, frustrations and expectations, coping styles, fear of COVID-19, resilience, arts and creative engagement, life events, weight, gambling behaviours, mental health diagnosis, use of financial support, faith and religion, relationships, neighbourhood satisfaction, healthcare usage, discrimination experiences, life changes, optimism, long COVID and COVID-19 vaccination.
Out of 575 survey participants in the U.S. who delayed purchasing a new vehicle during COVID-19 restrictions in 2020, nearly half of the participants claimed that they would feel comfortable buying a vehicle from a dealership within 30 days of the restrictions being lifted. Only three percent of respondents said that they would wait at least six months after restrictions have been lifted. Restrictions in the U.S. Like many countries worldwide, measures to slow down and control the spread of COVID-19 on a national scale were implemented across several U.S. states. Such measures included the temporary closure of schools, bars, restaurants, and movie theaters, along with the cancellation or postponement of several large public events. While online activity in the U.S. has steadily increased during the pandemic, e-tailers in the automotive industry are predicting a decrease in sales: projected auto sales growth for 2020 in the U.S. are anticipated to be 26.6 percent below the level one year earlier. Post-lockdown behavior Respondents in this survey were also asked whether they would feel comfortable performing other activities after COVID-19 restrictions were lifted. A total of 48 percent of respondents stated that they were comfortable buying a vehicle from a dealership within a month of restrictions being lifted, 67 percent claimed that they would feel comfortable returning to work, 51 percent would dine in at a restaurant, and only 22 percent would travel via airplane.
The "COVID-19 Reported Patient Impact and Hospital Capacity by Facility" dataset from the U.S. Department of Health & Human Services, filtered for Connecticut. View the full dataset and detailed metadata here: https://healthdata.gov/Hospital/COVID-19-Reported-Patient-Impact-and-Hospital-Capa/anag-cw7u The following dataset provides facility-level data for hospital utilization aggregated on a weekly basis (Friday to Thursday). These are derived from reports with facility-level granularity across two main sources: (1) HHS TeleTracking, and (2) reporting provided directly to HHS Protect by state/territorial health departments on behalf of their healthcare facilities. The hospital population includes all hospitals registered with Centers for Medicare & Medicaid Services (CMS) as of June 1, 2020. It includes non-CMS hospitals that have reported since July 15, 2020. It does not include psychiatric, rehabilitation, Indian Health Service (IHS) facilities, U.S. Department of Veterans Affairs (VA) facilities, Defense Health Agency (DHA) facilities, and religious non-medical facilities. For a given entry, the term “collection_week” signifies the start of the period that is aggregated. For example, a “collection_week” of 2020-11-20 means the average/sum/coverage of the elements captured from that given facility starting and including Friday, November 20, 2020, and ending and including reports for Thursday, November 26, 2020. Reported elements include an append of either “_coverage”, “_sum”, or “_avg”. A “_coverage” append denotes how many times the facility reported that element during that collection week. A “_sum” append denotes the sum of the reports provided for that facility for that element during that collection week. A “_avg” append is the average of the reports provided for that facility for that element during that collection week. The file will be updated weekly. No statistical analysis is applied to impute non-response. For averages, calculations are based on the number of values collected for a given hospital in that collection week. Suppression is applied to the file for sums and averages less than four (4). In these cases, the field will be replaced with “-999,999”. This data is preliminary and subject to change as more data become available. Data is available starting on July 31, 2020. Sometimes, reports for a given facility will be provided to both HHS TeleTracking and HHS Protect. When this occurs, to ensure that there are not duplicate reports, deduplication is applied according to prioritization rules within HHS Protect. For influenza fields listed in the file, the current HHS guidance marks these fields as optional. As a result, coverage of these elements are varied. On May 3, 2021, the following fields have been added to this data set. hhs_ids previous_day_admission_adult_covid_confirmed_7_day_coverage previous_day_admission_pediatric_covid_confirmed_7_day_coverage previous_day_admission_adult_covid_suspected_7_day_coverage previous_day_admission_pediatric_covid_suspected_7_day_coverage previous_week_personnel_covid_vaccinated_doses_administered_7_day_sum total_personnel_covid_vaccinated_doses_none_7_day_sum total_personnel_covid_vaccinated_doses_one_7_day_sum total_personnel_covid_vaccinated_doses_all_7_day_sum previous_week_patients_covid_vaccinated_doses_one_7_day_sum previous_week_patients_covid_vaccinated_doses_all_7_day_sum On May 8, 2021, this data set has been converted to a corrected data set. The corrections applied to this data set are to smooth out data anomalies caused by keyed in data errors. To help determine which records have had corrections made to it. An additional Boolean field called is_corrected has been added. To see the numbers as reported by the facilities, go to: https://healthdata.gov/Hospital/COVID-19-Reported-Patient-Impact-and-Hospital-Capa/uqq2-txqb On May 13, 2021 Changed vaccination fields from sum to max or min fields. This reflects the maximum or minimum number report
The New York Times is releasing a series of data files with cumulative counts of coronavirus cases in the United States, at the state and county level, over time. We are compiling this time series data from state and local governments and health departments in an attempt to provide a complete record of the ongoing outbreak.
Since late January, The Times has tracked cases of coronavirus in real time as they were identified after testing. Because of the widespread shortage of testing, however, the data is necessarily limited in the picture it presents of the outbreak.
We have used this data to power our maps and reporting tracking the outbreak, and it is now being made available to the public in response to requests from researchers, scientists and government officials who would like access to the data to better understand the outbreak.
The data begins with the first reported coronavirus case in Washington State on Jan. 21, 2020. We will publish regular updates to the data in this repository.